Skip to main content
STI 2024 Prevention Conference Main banner
Final Program


Abstract Book
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Jason Zucker, MD (he/him/his)

Assistant Professor of Medicine
Columbia University Irving Medical Center
New York, New York, United States

Dr. Jason Zucker is an Assistant Professor of Medicine in the Division of Infectious Diseases at Columbia University Medical Center and Assistant Medical Director of the New York City STD Prevention Training Center. Dr. Zucker trained as a combined adult and pediatric infectious diseases physician and is an experienced HIV, HIV prevention, and sexual health care provider providing status-neutral care to patients of all ages in the NewYork Presbyterian-Columbia Comprehensive Health Program Sexual Health Clinic. His research focuses on the intersection of data science, behavioral science, and implementation science, focusing on ways to optimize engagement in the sexual health cascade of care for individuals living with or at risk of sexually transmitted infections.

Given his focus on sexual health, Dr. Zucker has been actively involved in sexual health policy and research. He is a PI or co-PI on two NIH-funded studies, including STIckER, a digital patient decision aid designed to improve STI testing in the ED, and Doxy4STICare, which focus on engagement, effective use, and resistance in Doxy-PEP. Dr. Zucker is co-vice chair of the NIH-funded Study of Tecovirimat for Human Monkeypox Virus (STOMP), the randomized, placebo-controlled, double-blinded trial of the safety and efficacy of tecovirimat funded by the NIH and run by the AIDS Clinical Trials Group. He is also a co-investigator and site PI for the CDC-funded Life after Mpox (LAMP) and several other CDC mpox studies. He has co-written the “Questions, Answers, and Best Practices for Expedited Partner Therapy (EPT)” for the New York State AIDS Institute clinical guidelines program and participated in the New York State Congenital Syphilis Elimination Strategic Planning Group. He is a member of the 2024 STD Prevention Conference Scientific Program Committee and a medical consultant to the CDC for an upcoming version of the STI Treatment Guidelines.

Disclosure information not submitted.

Presentation(s):

Email Jason